does cjc-1295 work: Frequently asked questions

Run parallel arms with matched GH exposure, not matched doses. CJC-1295 with DAC requires lower total weekly dose than Modified GRF 1-29 to achieve equivalent IGF-1 elevation because sustained receptor engagement is more efficient than repeated pulses. A typical comparison might use 1 mg CJC-1295 with DAC weekly versus 3 mg Modified GRF 1-29 split across 21 doses (100 mcg three times daily). Measure both GH (via serial sampling) and IGF-1 (weekly) to capture the kinetic differences. Expect Modified GRF to show higher peak GH but lower average GH; DAC will show lower peaks but higher average and more stable IGF-1.

Use CJC-1295 without DAC (Modified GRF 1-29) instead. The DAC modification flattens peak GH response by maintaining steady baseline elevation. You'll see higher troughs but lower peaks compared to non-DAC formulations. If your endpoint is peak GH amplitude (e.g., post-exercise GH surge, sleep-stage correlation), DAC obscures the measurement. Modified GRF 1-29 clears within 30 minutes, allowing endogenous pulses to resume on schedule and preserving the dynamic range needed for acute response studies.

Use Modified GRF 1-29 (CJC-1295 without DAC) or sermorelin instead. CJC-1295 with DAC produces continuous low-level GH secretion rather than physiological pulsatility. This is ideal for sustained metabolic studies but incompatible with circadian rhythm research or pulsatile receptor studies. The DAC modification cannot be removed post-reconstitution; choosing the wrong peptide variant invalidates the study design.

Discard it. The maleimidopropionyl reactive group that enables DAC-albumin binding degrades irreversibly above 8°C. Even brief temperature excursions during shipping can render the modification non-functional. The peptide may still stimulate GH release via GHRH receptor binding, but plasma retention will collapse to under 30 minutes, identical to non-DAC analogues. There is no home test for DAC linker integrity; if storage temperature was not continuously maintained at −20°C, assume the extended half-life property is lost.

Assume it's Modified GRF 1-29 (non-DAC) unless explicitly labeled otherwise. True CJC-1295 with DAC is more expensive to synthesize due to the DAC conjugation step, so vendors who stock it advertise that feature prominently. If the product listing shows CJC-1295 at a suspiciously low price or doesn't mention DAC, it's almost certainly the non-DAC version. Request third-party HPLC purity testing and verify the molecular weight. DAC addition increases MW by approximately 2 kDa, detectable in mass spectrometry. Suppliers like Real Peptides provide batch-specific purity certificates confirming DAC presence and overall purity above 98%.

Verify reconstitution technique first. Injecting air into the vial while drawing the peptide solution creates positive pressure that can pull contaminants back through the needle on subsequent draws. Bacterial contamination accelerates peptide degradation even under refrigeration. Use a separate sterile needle for each draw and never inject air into multi-dose vials. If technique is correct and plasma levels still decline prematurely, the batch may have experienced cold chain breaks during manufacturing or shipping.